Selecting an accurate point-of-care testing system: clinical and technical issues and implications in neonatal blood glucose monitoring.
Rapid identification and treatment of glucose abnormalities is crucial in the prevention of potentially devastating neurological injury in neonates. Choice of a point-of-care glucose testing system must consider accuracy, clinical advantages, and data management capabilities. The benefits and limitations of point-of-care testing must be weighed against the time delay of central laboratory testing. Considerations in selecting a point-of-care blood glucose monitoring system include accuracy, precision, versatility, and the potential for cross infection and blood loss. When a system is selected, studies must be done to identify potential sources of error and confirm the utility and accuracy of the system in the identified population.